Saudi Food and Drug Authority - Regulatory authority for pharmaceuticals and medical devices in Saudi Arabia
显示 2020 年的审批记录
仅限当前页。暂不支持搜索完整审批数据集。
药物名称 | 公司 | 适应症 | 日期 | 类型 |
|---|---|---|---|---|
| Esperoct | Novo Nordisk Bagsvaerd | Powder and solvent for solution for injection | Jan 1, 2020 | Biological |
| Pomalidomide SPC | Dr. Reddy’s Laboratories Ltd. Formulation Unit VII | Capsule, hard | Jan 1, 2020 | Generic |
| Hyrimoz | Novartis Pharmaceutical Manufacturing GmbH | Solution for injection | Jan 1, 2020 | Biological |
| ATRACURIUM BESYLATE 10MG-ML AMP | Wasserburger arzneimittel werk GmbH | Solution for injection | Jan 1, 2020 | NCE |
| DIAOPTIM MR | LES LABORATOIRES SERVIER INDUSTRIE | modified-release tablet | Jan 1, 2020 | Generic |
| TRIVACIN 4.6MG/24H TRANSDERMAL PATCHES | Luye Pharma AG | Transdermal patch | Jan 1, 2020 | Generic |
| Dovato | GLAXOSMITHKLINE (GSK) | Film-coated tablet | Jan 1, 2020 | NCE |
| Pevas | UNITED PHARMACEUTICAL COMPANY | Film-coated tablet | Jan 1, 2020 | Generic |
| GARDIA PLUS 8/12.5MG TABLETS | UNITED PHARMACEUTICAL COMPANY | Tablet | Jan 1, 2020 | Generic |
| EXITINE | MS Pharma | Solution for infusion | Jan 1, 2020 | Generic |
| AVOBAN 2% W-W OINTMENT | (Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd | Ointment | Jan 1, 2020 | Generic |
| GADOVIST 1MMOL-ML PRE-FILLED SYRINGE | BAYER AG | Solution for injection | Jan 1, 2020 | NCE |
| GARDIA PLUS 16/12.5MG TABLETS | UNITED PHARMACEUTICAL COMPANY | Tablet | Jan 1, 2020 | Generic |
| MOPIZALE 500MG/100ML SOLUTION FOR INFUSION | MS Pharma | Solution for infusion | Jan 1, 2020 | Generic |
| DEFRA 240MG DELAYED RELEASE CAPSULES | Macleods Pharmaceuticals Ltd. | Delayed-release capsule | Jan 1, 2020 | Generic |
| VOSTRAN 2MG/ML SOLUTION FOR INJECTION | MS Pharma | Solution for injection | Jan 1, 2020 | Generic |
| Debilur | TABUK PHARMACEUTICAL MANUFACTURING CO. | Film-coated tablet | Jan 1, 2020 | Generic |
| FONTAX 20 mg film-coated tablet | MEDOCHEMIE LTD | Film-coated tablet | Jan 1, 2020 | Generic |
| NEXIUM 40MG TAB | AstraZeneca AB | Gastro-resistant tablet | Jan 1, 2020 | NCE |
| RESEDRA 1MG/ML ORAL SOLUTION | SPIMACO | Oral solution | Jan 1, 2020 | Generic |
